Price movement over the last 24 hours
Arkham vs Mitosis — how do they compare? Arkham trades at Rp1,996 (market cap Rp450,91M, Rp512,92M 24h volume), while Mitosis trades at Rp362.37 (market cap Rp65,88M, Rp94,65M 24h volume). The key difference: Arkham is far larger — about 6.8× Mitosis's market cap, and Arkham's circulating supply is 225,1M / 1B ARKM (23%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Arkham for 49 Days and Mitosis for 19 Days on average.
| ARKM | MITO | |
|---|---|---|
Market Cap | Rp450,91M | Rp65,88M |
Volume (24h) | Rp512,92M | Rp94,65M |
Circulating Supply | 225,1M / 1B ARKM (23%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 49 Days | 19 Days |
Signals from Pluang's Aura AI — not financial advice
ARKM is currently trading at Rp1,971 with a bearish technical signal, showing selling pressure across moving averages while oscillators remain neutral. The token trades below the pivot point of Rp2,048 with immediate support at Rp1,951. With only 23% of the maximum 1 million token supply in circulation and an average hold time of 49 days, the asset shows limited distribution but stable holding patterns among current investors.
The overall outlook remains cautious due to strong bearish technical signals and limited fundamental developments. Key opportunities include potential price stabilization near support levels, while major risks involve low liquidity with Rp453.71M market cap and the absence of recent ecosystem updates that could drive adoption.
Mitosis (MITO) is trading at Rp393.33 with a market cap of Rp71.86 million, showing a bearish technical outlook as moving averages signal strong selling pressure while oscillators remain neutral. The token's low circulating supply of 181,300 out of 1 million tokens and short average hold time of 19 days suggest high volatility. Recent news highlights a strategic acquisition involving MITO Material Solutions, though this pertains to a corporate entity and not the cryptocurrency's ecosystem.
Overall outlook is cautious due to bearish technical signals and limited liquidity. Key opportunities include potential price rebounds from oversold RSI levels, but major risks involve low market cap volatility, minimal exchange presence, and lack of clear token utility updates. Investors should monitor for genuine protocol developments rather than unrelated corporate news.
What Pluang investors did over the last 30 days
Arkham is a blockchain analysis platform that uses artificial intelligence to deanonymize the blockchain and on-chain data. Arkham’s platform can be used for various purposes, such as tracking stolen funds, identifying fraudsters, verifying counterparties, auditing transactions, investigating hacks, and more. Arkham claims its platform can help combat the proliferation of crypto crimes and scams by incentivizing on-chain research.
Read more on ARKM →Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →